当前位置:首页 - 行情中心 - 和元生物(688238) - 财务分析

和元生物

(688238)

  

流通市值:18.25亿  总市值:25.31亿
流通股本:4.67亿   总股本:6.47亿

和元生物(688238)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年半年度实现净利润-1.14亿元,每股收益-0.18元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年半年度最新股东权益194327.44万元,未分配利润-15755.94万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年半年度最新总资产248251.54万元,负债53924.10万元。

利润表
报告期2024-06-302024-03-312023-12-312023-09-30
营业总收入113,061,626.5659,574,128.09204,805,008.26136,994,292.35
营业总成本236,598,085.89117,835,749.83360,583,467.55229,680,716.89
营业利润-113,277,855.98-50,934,967.48-155,446,013.49-87,679,634.77
利润总额-113,364,814.42-50,916,764.65-155,603,609.01-87,648,982.37
净利润-113,602,460.19-42,298,770.28-127,813,694.42-71,004,439.21
其他综合收益-2,452,339.41-438,211.74372,939.21591,384.38
综合收益总额-116,054,799.6-42,736,982.02-127,440,755.21-70,413,054.83
资产负债表
报告期2024-06-302024-03-312023-12-312023-09-30
流动资产合计777,734,253.13860,070,593.23927,449,840.461,042,574,556.3
非流动资产合计1,704,781,100.841,708,893,596.691,676,042,385.041,578,922,037.9
资产总计2,482,515,353.972,568,964,189.922,603,492,225.52,621,496,594.2
流动负债合计323,984,455.34326,155,400.73314,170,964.15261,426,763.42
非流动负债合计215,256,540.44226,237,507.24230,953,200.83239,741,849.35
负债合计539,240,995.78552,392,907.97545,124,164.98501,168,612.77
归属于母公司股东权益合计1,943,406,805.662,016,575,124.482,058,243,425.092,120,232,850.1
股东权益合计1,943,274,358.192,016,571,281.952,058,368,060.522,120,327,981.43
负债和股东权益合计2,482,515,353.972,568,964,189.922,603,492,225.52,621,496,594.2
现金流量表
报告期2024-06-302024-03-312023-12-312023-09-30
经营活动现金流入小计117,674,388.8559,721,797.22293,584,621.85177,897,526.64
经营活动现金流出小计232,304,223.28122,264,101.41383,706,438.45257,118,253.64
经营活动产生的现金流量净额-114,629,834.43-62,542,304.19-90,121,816.6-79,220,727
投资活动现金流入小计38,781,365.7228,685,449.94293,023,436.85225,904,250.16
投资活动现金流出小计147,791,841.89112,499,033.84894,576,787.27721,843,995.6
投资活动产生的现金流量净额-109,010,476.17-83,813,583.9-601,553,350.42-495,939,745.44
筹资活动现金流入小计60,000,00060,000,000154,728,894154,734,490.8
筹资活动现金流出小计7,865,969.462,797,692.0320,609,039.5215,057,253.16
筹资活动产生的现金流量净额52,134,030.5457,202,307.97134,119,854.48139,677,237.64
汇率变动对现金及现金等价物的影响61,029.49-952,940.87-33,435.15286,280.72
现金及现金等价物净增加额-171,445,250.57-90,106,520.99-557,588,747.69-435,196,954.08
期末现金及现金等价物余额481,541,549.4562,880,278.98652,986,799.97775,378,593.58
最新报告期:2024-09-01
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
中金公司张琎,吴婉桦-0.35-0.34--2024-09-01
TOP↑